Skip to main content
. 2021 Jul 8;31(7):1086–1095. doi: 10.1089/thy.2020.0689

Table 4.

Rate of Overall Survival and Probability That Patients Would Remain Free of Thyroid Malignancy up to 15 Years by Diagnostic Category

Cytologic diagnosis Patients (n) Free of thyroid malignancy (%)
Overall survival (%)
1 Year 5 Years 10 Years 15 Years Still in study 15 Years
Benign 1575 99.1 ± 0.2 97.9 ± 0.4 97.1 ± 0.4 96.6 ± 0.4 512 1.00
Nondiagnostic 236 94.5 ± 1.5 93.2 ± 1.6 93.2 ± 1.6 93.2 ± 1.6 126 1.00
AUS/FLUS 135 76.3 ± 3.7 76.3 ± 3.7 75.6 ± 3.7 75.6 ± 3.7 38 98.5 ± 1.0
 AUS 57 66.7 ± 6.2 66.7 ± 6.2 66.7 ± 6.2 66.7 ± 6.2 21 1.00
 FLUS 78 83.3 ± 4.2 83.3 ± 4.2 83.3 ± 4.2 82.1 ± 4.4 17 97.4 ± 1.8
Follicular neoplasm 107 73.8 ± 4.2 71.0 ± 4.4 71.0 ± 4.4 71.0 ± 4.4 34 97.3 ± 1.9
SUS 20 30.0 ± 10.2 30.0 ± 10.2 30.0 ± 10.2 30.0 ± 10.2 10 95.0 ± 4.9
Malignant 134 0.7 ± 0.07 n/a n/a n/a 41 93.1 ± 2.2